Novel insights into the pathogenesis of uric acid nephrolithiasis.
about
Effect of soda consumption on urinary stone risk parameters.Metabolic evaluation of first-time and recurrent stone formers.Characterization of the regulation of renal Na+/H+ exchanger NHE3 by insulin.Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion.Fasting versus 24-h urine pH in the evaluation of nephrolithiasis.Metabolic basis for low urine pH in type 2 diabetes.Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management.Metabolic syndrome and the genesis of uric acid stones.Pharmacology of stone diseaseRecent advances in the pathophysiology of nephrolithiasis.Advances in the management of gout: critical appraisal of febuxostat in the control of hyperuricemia.Hypercalciuria associated with high dietary protein intake is not due to acid loadNephrolithiasis: Endocrine evaluation.Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohortThe diurnal variation in urine acidification differs between normal individuals and uric acid stone formersApproach to the Adult Kidney Stone Former[Effect of the body mass index on outcomes of ureterorenoscopy for renal stones].Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community.Epidemiology and clinical pathophysiology of uric acid kidney stones.Renal stone disease: Causes, evaluation and medical treatment.Medical management of urinary stone disease.Kidney stones: an update on current pharmacological management and future directions.CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 updateBeware the low urine pH--the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetes.Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence.Redefining the Stone Belt: Precipitation is Associated with Increased Risk of Urinary Stone Disease.Furosemide/Fludrocortisone Test and Clinical Parameters to Diagnose Incomplete Distal Renal Tubular Acidosis in Kidney Stone Formers.Risks associated with drug treatments for kidney stones.Treatment of patients with uric acid stones.Differences in Urinary Stone Composition according to Body Habitus.Biochemical and dietary factors of uric acid stone formation.The Association of Uric Acid Calculi with Obesity, Prediabetes, Type 2 Diabetes Mellitus, and Hypertension.Epidemiology, pathophysiology, and management of uric acid urolithiasis: A narrative review.An Increase Incidence in Uric Acid Nephrolithiasis: Changing Patterns.Compositional analysis of various layers of upper urinary tract stones by infrared spectroscopy.Biochemical diagnosis in 3040 kidney stone formers in Argentina.Metabolic syndrome and urologic diseases.Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with gout.Effect of the body mass index on outcomes of flexible ureterorenoscopy.Composition, microstructure and element study of urinary calculi.
P2860
Q33682464-167875C2-34CC-4482-BC9B-E4B9E4068932Q33737379-93D269C5-F095-4775-98D2-6BAE7F8BCA8EQ33818214-7C631C4C-549C-48BB-8A1D-87ED188BAD0FQ33818281-E6477795-2362-4DE7-9B76-C7088C453C75Q33923986-9257AB44-B9E3-4588-AA1B-E2019F7DEFB5Q33944756-0000EF2C-CC40-4ECF-9B30-CE02564A893AQ34265048-303A1EE0-5B3C-4F00-9D04-7AC72C645714Q34645361-4917E150-D087-4031-B092-CBC7CFACC497Q34936294-7DDF6CB6-AEDA-4CFE-A69B-15E38351DA3AQ34936316-2F17D0D5-1E62-4F4C-808B-FF6640C112B4Q35026721-35C79C91-7F8F-4A24-B8EB-C329EF1ED04AQ35597900-F88C991B-AE4F-4CBA-B9F8-A38E147E2099Q35856057-E15CE68C-2FBF-4A0D-93F8-4539AD1902EEQ35896622-6765745A-955E-4A84-A52F-8F31E72DBF6FQ35962409-58868AAF-EA77-41FE-A6E1-A672D2CA25C8Q35990584-88B747DF-E2B6-46D3-9E6F-E80A0541B5FAQ36043711-09E76B52-C6EC-41A2-A23E-4CAFE5C69880Q36122526-47CE3D8C-F7C5-40A7-A488-C5F48F1D436BQ36417612-713C69E9-E575-46A4-AA37-4C29C13EB821Q36658996-B6A15D33-9482-4017-8570-47D6621F44DBQ36828140-D6DB125C-2E9A-4FCD-BB27-648C35F22982Q37169623-B36D2F53-E103-4037-B656-A43680FD40C6Q37585262-0F0476F7-CD59-4098-8514-87C5B6243F10Q37944893-0CADF0E7-4969-482A-A7D5-9A7A3FC4B8B0Q38201688-9B683DF2-3B99-43A7-A1EA-7B0B5D1AFB97Q38613863-79BD0C2E-6D5D-4506-BBBC-A856AB3D53EDQ38642388-731538FC-792E-46DF-9DD3-9215B706A498Q38645658-76D58771-2DD9-4F16-8CD1-E329E6DAE33DQ38662261-243ED980-1D9B-42C2-B92E-0BA9AAA40E94Q38776852-15F69B2D-B4A4-4E8D-8D2F-A959027E0870Q38936572-AE701AB9-4B64-47B5-BF8B-28B0D6DF9A4BQ40044623-B41344FC-0F65-4103-B6E5-C43D65D6E7F0Q40106733-304A3C16-78A7-4DD4-B908-869BB15F03E4Q41072156-A7B94725-4787-4E59-BA42-456048906345Q41623733-D5F36D88-0157-45AF-A0AB-FB819FEEAC2FQ41750340-54CF0E8D-6441-4F74-8726-8497D6BEC022Q42757693-FFB136B0-9414-446B-9A84-C0AE06356176Q43053234-A7F61E62-77FD-484C-925F-908784A28CE1Q45349119-7A852243-3608-4DA3-A1DF-B7364DB2C821Q47965385-030FBF60-E4C4-4B67-923F-5A52225330DF
P2860
Novel insights into the pathogenesis of uric acid nephrolithiasis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Novel insights into the pathogenesis of uric acid nephrolithiasis.
@ast
Novel insights into the pathogenesis of uric acid nephrolithiasis.
@en
type
label
Novel insights into the pathogenesis of uric acid nephrolithiasis.
@ast
Novel insights into the pathogenesis of uric acid nephrolithiasis.
@en
prefLabel
Novel insights into the pathogenesis of uric acid nephrolithiasis.
@ast
Novel insights into the pathogenesis of uric acid nephrolithiasis.
@en
P2093
P1476
Novel insights into the pathogenesis of uric acid nephrolithiasis.
@en
P2093
Khashayar Sakhaee
Mary Ann Cameron
Naim M Maalouf
Orson W Moe
P304
P356
10.1097/00041552-200403000-00006
P577
2004-03-01T00:00:00Z